While our primary prognostic model is based on the 18 ARGs associated with overall survival, our metastatic subgroup analysis identified MMP9 as a critical molecular bridge linking anoikis resistance to the metastatic cascade in ccRCC. This evidence concerns the gene MMP9 and nonpapillary renal cell carcinoma.